Print page content Print
Increase text size Decrease text size
Text Size


Campylobacter Fetus Bacterin


Vibrin® is for vaccination of healthy cows and heifers as an aid in preventing campylobacteriosis (vibriosis) caused by Campylobacter fetus. Vibrin is prepared from an inactivated, concentrated suspension of Campylobacter fetus, bovine isolate, in a patented repository base.

Collapse All
  • Uses

    Aids in the prevention of campylobacteriosis (vibriosis) caused by Campylobacter fetus.

    Key Features

    • Helps protect against campylobacteriosis (vibriosis), a common but difficult-to-detect reproductive disease of cattle.
    • A single dose is effective.
    • May be given as early as seven months before breeding, making it ideal for use at fall pregnancy check.
    • Single subcutaneous (SC) dose is 2mL, given to all breeding cows and heifers between 30 days and seven months before breeding.

    Safety and Efficacy

    Chemical inactivation renders Vibrin incapable of causing or spreading infectious disease. The special adjuvant base enhances and prolongs antigenic stimulation and may produce a localized vaccine granuloma. These are noninflammatory, however, and usually disappear in several weeks. Field use and extensive, controlled tests in breeding cattle under experimental conditions demonstrated that the serotype of Campylobacter fetus used in Vibrin was effective in prevention of campylobacteriosis.
    Pregnancy rates in vaccinated heifers were up to 44% higher than in nonvaccinated control heifers. All research conducted on Vibrin indicated a single dose is effective and there is no advantage in using multiple injections.

  • Precautions:

    1. Store at 2°–7°C. Prolonged exposure to higher temperatures may adversely affect potency. Do not freeze.
    2. Use entire contents when first opened.
    3. Sterilized syringes and needles should be used to administer this vaccine.
    4. To avoid vaccination site trim-out, do not vaccinate within 60 days before slaughter.
    5. As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.
    6. This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised, or is not administered in accordance with label directions.



Mon–Fri, 8:30am–8:00pm ET

This site is intended for U.S. Animal Healthcare Professionals. The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2021 Zoetis Services LLC. All rights reserved.